1. Home
  2. TREX vs EWTX Comparison

TREX vs EWTX Comparison

Compare TREX & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trex Company Inc.

TREX

Trex Company Inc.

HOLD

Current Price

$39.26

Market Cap

3.9B

Sector

N/A

ML Signal

HOLD

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

HOLD

Current Price

$32.50

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TREX
EWTX
Founded
1996
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.3B
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
TREX
EWTX
Price
$39.26
$32.50
Analyst Decision
Buy
Buy
Analyst Count
17
6
Target Price
$49.53
$39.00
AVG Volume (30 Days)
1.9M
1.2M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.58
N/A
Revenue
$1,174,267,000.00
N/A
Revenue This Year
$5.09
N/A
Revenue Next Year
$6.24
N/A
P/E Ratio
$66.77
N/A
Revenue Growth
1.98
N/A
52 Week Low
$29.77
$12.31
52 Week High
$68.78
$39.96

Technical Indicators

Market Signals
Indicator
TREX
EWTX
Relative Strength Index (RSI) 51.15 47.86
Support Level $35.25 $27.81
Resistance Level $44.76 $35.00
Average True Range (ATR) 2.00 1.69
MACD -0.04 -0.27
Stochastic Oscillator 40.30 15.66

Price Performance

Historical Comparison
TREX
EWTX

About TREX Trex Company Inc.

Trex Co Inc is a manufacturer of wooden alternative decking products. The company offers outdoor products in the decking, railing, porch, fencing, trim, steel deck framing, and outdoor lighting categories. Its products are sold under the Trex brand and manufactured in the United States. Further, the company licenses its Trex brand to third parties to manufacture and sell products under the Trex trademark. The distribution is focused on wholesale distributors and retail lumber dealers, which in turn sell Trex products to homeowners and contractors, with an emphasis on professional contractors, remodelers, and homebuilders. The company operates in one reportable segment i.e. Trex Residential.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.

Share on Social Networks: